Zhihua Lv
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies 5
- SARS-CoV-2 and COVID-19 Research 4
- SARS-CoV-2 detection and testing 3
- Modeling and Simulation top 5%
- Neurology top 10%
- Long-Term Effects of COVID-19 3
-
- Biofuel production and bioconversion 6
-
- Enzyme Production and Characterization 6
-
- Enzyme Catalysis and Immobilization 4
-
- Cancer-related molecular mechanisms research 3
- Co-authors
- Chengliang ZhuYong FengYingle LiuHuan HanRui LiuKailang WuFang LiuJingtao Huang
In The Last Decade
Zhihua Lv
25 papers receiving 756 citations
Peers
Comparison fields: 5 of 96
- Infectious Diseases 502
- Applied Microbiology and Biotechnology 30
- Modeling and Simulation 44
- Neurology 106
- Radiology, Nuclear Medicine and Imaging 123
Countries citing papers authored by Zhihua Lv
This map shows the geographic impact of Zhihua Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhihua Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhihua Lv more than expected).
Fields of papers citing papers by Zhihua Lv
This network shows the impact of papers produced by Zhihua Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhihua Lv. The network helps show where Zhihua Lv may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhihua Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2025 | 0 | |
| 7 | 2025 | 3 | |
| 8 | 2025 | 0 | |
| 9 | 2025 | 0 | |
| 10 | 2024 | 6 | |
| 11 | 2024 | 3 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 2 | |
| 14 | 2023 | 3 | |
| 15 | 2023 | 2 | |
| 16 | 2020 | 100 | |
| 17 | 2020 | 417 | |
| 18 | Cluster of specified microRNAs in tissues and serum as biomarkers for early diagnosis of hepatocellular carcinoma. | 2018 | 5 |
| 19 | 2016 | 15 | |
| 20 | 2014 | 26 |
About Zhihua Lv
Zhihua Lv is a scholar working on Biotechnology, Infectious Diseases and Microbiology, having authored 32 papers that have together received 770 indexed citations. Recurring topics across this work include Biofuel production and bioconversion (6 papers), Enzyme Production and Characterization (6 papers), COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Enzyme Catalysis and Immobilization (4 papers), SARS-CoV-2 detection and testing (3 papers), Cancer-related molecular mechanisms research (3 papers) and Long-Term Effects of COVID-19 (3 papers). The work is most often cited by research in Infectious Diseases (502 citations), Applied Microbiology and Biotechnology (30 citations) and Modeling and Simulation (44 citations). Zhihua Lv has collaborated with scholars based in China and Nigeria. Frequent co-authors include Chengliang Zhu, Yong Feng, Yingle Liu, Huan Han, Rui Liu, Kailang Wu, Fang Liu, Jingtao Huang, Lina Feng and Juan Le. Their work appears in journals such as Clinical Infectious Diseases, Scientific Reports and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.